Found: 6
Select item for more details and to access through your institution.
Patients with hereditary hemochromatosis reach safe range of transferrin saturation sooner with erythrocytaphereses than with phlebotomies.
- Published in:
- Journal of Clinical Apheresis, 2022, v. 37, n. 1, p. 100, doi. 10.1002/jca.21956
- By:
- Publication type:
- Article
A predictive model for estimating the number of erythrocytapheresis or phlebotomy treatments for patients with naïve hereditary hemochromatosis.
- Published in:
- Journal of Clinical Apheresis, 2021, v. 36, n. 3, p. 340, doi. 10.1002/jca.21867
- By:
- Publication type:
- Article
A comment on: "Proton pump inhibition for secondary hemochromatosis in hereditary anemia: a phase III placebo‐controlled randomized cross‐over clinical trial".
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 12, p. E482, doi. 10.1002/ajh.26740
- By:
- Publication type:
- Article
Response to can modifier gene mutations improve the predictive value of the modified Iron Avidity Index in Type 1 Hereditary Haemochromatosis?
- Published in:
- Liver International, 2016, v. 36, n. 11, p. 1714, doi. 10.1111/liv.13169
- By:
- Publication type:
- Article
The modified iron avidity index: a promising phenotypic predictor in HFE-related haemochromatosis.
- Published in:
- Liver International, 2016, v. 36, n. 10, p. 1535, doi. 10.1111/liv.13121
- By:
- Publication type:
- Article
Inflammation can increase hepcidin in HFE‐hereditary hemochromatosis.
- Published in:
- Clinical Case Reports, 2021, v. 9, n. 5, p. 1, doi. 10.1002/ccr3.4114
- By:
- Publication type:
- Article